02-01-2026 17:37 via drugs.com

Semaglutide May Lower Burden of Hospitalizations in High-Risk Patients

FRIDAY, Jan. 2, 2026-- For patients at high cardiovascular risk with overweight or obesity, semaglutide is associated with reduced burden of total hospital admissions, according to a study published online Dec. 23 in JAMA Cardiology.Stephen J...
Read more »

Pharmaceutical news



Risk for Suicide Attempt Increased in Association With Head Injuries
FDA Approves Myqorzo for Symptomatic Obstructive Hypertrophic Cardiomyopathy
Email Communications Improve Clinician Engagement With Prescription Drug Monitoring Programs
Incretin Receptor Agonists Tied to Better Outcomes in Adults With Obesity, T2DM, Obstructive Sleep Apnea
Geographic Differences in Antibiotic Nonsusceptibility Patterns Seen for Travelers' Diarrhea
Few Women Meet Aerobic, Muscle-Strengthening Activity Recommendation
Airline Water Safety Raises Red Flags in New Study
Alterations in Gut Microbiome Seen Early in Inflammatory Bowel Disease
Diet May Influence Tinnitus Risk in Women
Statin Initiation Beneficial in T2DM, Regardless of Cardiovascular Risk
Weaker, More Fragmented Circadian Rhythms May Increase Dementia Risk
Age Does Not Affect Neurologic Recovery After Spinal Cord Injury
U.S. Sees Highest Measles Case Count in Decades as Outbreaks Grow
New Study Explains Why Brains Process Information at Different Speeds
Desktop versie